Dr. Ilias of Greece Announces the Effectiveness of ‘SMART M-CELL’ Treatment
Miracell, a stem cell company, announced on the 31st that it participated in the ‘2024 IV CONGRESO SEMDOR VALENCIA,’ hosted by the Spanish Pain Society and held at the Sercotel Sorolla Hotel in Valencia, Spain, for three days from October 24th.
‘CONGRESO SEMDOR 2024’ is a medical conference where pain treatment experts meet to exchange knowledge, share experiences, and explore the latest research and developments in the field of pain treatment.
This year’s theme was ‘Advancements in Pain Treatment: Innovation, Interdisciplinarity, and Quality of Care.’ Presenters included physicians from Spain, the UK, the US, the Netherlands, Canada, Greece, and Italy, with presentations focused on finding effective solutions to prevent and treat pain.
Miracell was invited to participate in this conference by Spanish buyer SIEBEN and the Spanish Society of Pain Medicine (SEMDOR).
It showcased its stem cell extraction system, SMART M-CELL, and its dedicated kit, drawing significant attention from doctors from around the world.
On the 25th, Dr. Theodoropoulos Ilias, a doctor of hematology from Greece, and Dr. Luis Miguel Torres, an associate professor at the University of Cadiz in Spain and a specialist in regenerative medicine and pain management, presented a workshop titled “Workshop on General Stem Cell Management in Regenerative Medicine.” They presented on the differences between IV and stem cell therapy, as well as the therapeutic applications and clinical efficacy of Miracell’s “SMART M-CELL,” capturing the attention of attending doctors.
Dr. Ilias stated, “After implementing Smart M-Cell, I received an intravenous stem cell injection to experience it firsthand. Even though it wasn’t a local injection, my previously unpleasant back pain disappeared and I felt a significant improvement in my health.”
He continued, “Over the past year, I’ve treated over 400 patients with stem cells, including IV injections. Having personally witnessed the remarkable results, I want to share the remarkable regenerative power and effective therapeutic effects of stem cells.”
“I will also write a paper based on the clinical treatment data so far.”
Miracell plans to collaborate with Dr. Ilias to gather patient treatment data from countries where Smart M-Cell is being used, share opinions on clinical effects, and organize a global conference where they can present their findings.
Meanwhile, SIEBEN, a medical device distribution company that has signed an exclusive import contract for SmartMcell in Spain, stated, “With the performance and therapeutic effects of SmartMcell being showcased at this year’s Spanish Pain Congress, many hospitals are expressing interest in introducing it.” They added, “It is currently being supplied to several hospitals, including university hospitals. Following coordination with Miracell on import customs clearance schedules, distribution in Spain is expected to begin in earnest early next year.”
Source: Medical Today (https://mdtoday.co.kr/)